According to the anticancer efficiency of both AA and VPA, we investigated whether decreased cancer cell viability was associated with increased SVCT2 expression, as determined in shSVCT2 HCT-116 cells, VPA treatment significantly reduced SVCT2 expression levels in the compared to shscramble control cells. This evidence concerns the gene SLC23A2 and cancer.